To clot or not to clot - that is the big question when it comes to many serious blood disorders. Abnormalities in the blood's protein can mean that clots form too easily (as in fatal embolism) or not easily enough (as in the various forms of hemophilia). By researching these abnormalities and teaching future doctors and researchers, Rodney Camire may have a role in improving treatment for children who have blood-related diseases.
The magna cum laude biochemistry graduate received tenure at the University of Pennsylvania School of Medicine, where he teaches biochemistry, supervises post-doctoral students, and facilitates bioethics workshops. He is also a researcher at the Children's Hospital of Philadelphia, which has one of the largest pediatric research programs in the country.
Since graduating from Saint Anselm, Rodney has earned a Ph.D. in biochemistry at the University of Vermont and completed a post-doctoral fellowship at the University of Pennsylvania. He has received numerous young investigator awards at national and international medical forums, published extensively, lectured widely and received research grants from national foundations as well as the National Institutes of Health. He lives in New Jersey with his wife, Tracey, and three children.
Please note: links will download PDF documents
- Curriculum Vitae
- From the Journal of Biological Chemistry: Prothombinase assembly as S1 site occupation restores the catalytic activity of FXa impared by mutation at the sodium-binding site. (277, 37863-37870, 2002.)
- From the Journal of Thrombosis and Haemostasis: The molecular basis of factor V and VIII procofactor activation. (7, 1951-1961, 2009. PMCID: PMC2993324.)